PFCD's @KennethThorpe sits down with @CancerSupportHQ's Daneen Sekoni to discuss what proposed Most Favored Nation (MFN) drug pricing policies could mean for people living with cancer. They explore the importance of timely access to innovative cancer treatments, the potential impact of importing foreign pricing policies, implications for health equity, and how policymakers can address affordability without jeopardizing access to the next generation of breakthrough therapies. WATCH: youtu.be/xktQ6x1GHcY

Kidney disease is a major burden for patients in Pennsylvania, with 4,400 likely to develop kidney failure this year. At the start of 2025, Medicare implemented a new policy that is compounding the burden, and it's time for lawmakers to act. - @KennethThorpe pennlive.com/opinion/2026/08…

America spends too much treating preventable complications from chronic disease. In @DCJournal, @KennethThorpe explains why insurance reform can lower costs and improve health. READ: dcjournal.com/the-road-to-a-…

West Virginians with kidney disease drive hours for dialysis, navigate rural care deserts, and manage a life-threatening illness. A Medicare bureaucratic decision is now adding one more obstacle. Read more from @KennethThorpe on to how to fix this: wvnews.com/theet/opinion/wes…

In this episode of Chronic Choices, Critical Voices, @pfcd's @KennethThorpe talks with @nmqf's Gary Puckrein on how proposed Most Favored Nation (MFN) drug pricing policies could affect patients living with chronic diseases. They explore the potential unintended consequences for Medicaid beneficiaries, the importance of preserving medical innovation, the role of health equity in drug development, concerns surrounding quality-adjusted life year (QALY) frameworks, and policy solutions that can improve affordability while ensuring patients continue to have timely access to life-saving treatments. youtu.be/et4CL3ZYP8Q

New blood-based biomarker tests offer a less invasive and more accessible way to detect Alzheimer’s. But coverage gaps persist, particularly regarding Medicare’s ability to cover blood tests as screening tools. Working to close those gaps, strengthen the role of primary care in early detection, and ensure that these new tools reach the patients who need them most are critical to making progress against this costly chronic disease. pfcdalz.org/alzheimers

PFCD remains committed to supporting continued research, thoughtful evaluation of evidence, and policies that accelerate progress for the millions of Americans affected by Alzheimer's disease. fightchronicdisease.org/post… #Fight4Health #EndAlz

For millions living with chronic conditions, pain isn’t occasional, it’s daily. And for too long, relief came with serious risks. New non-opioid therapies show patients shouldn’t have to choose between managing pain and protecting their future. That’s the kind of innovation patients deserve. inc.com/chase-feiger/the-opi… #Fight4Health

Advancing standards of care for the 7 million people navigating the challenges of #Alzheimers is critical to making America healthy and must remain a priority for Congress. #Fight4Health #EndAlz thehill.com/p/healthcare/575…

Although Congress has expressly prohibited the use of QALYs by certain federal programs to avoid discriminatory impacts, the "Most Favored Nation" executive order and the new Medicare/Medicaid models effectively import QALY-based valuations through international reference pricing. @KennethThorpe @joeymattingly healthaffairs.org/content/fo…

How would tying U.S. drug prices to those in foreign countries through a “Most Favored Nation” model impact Medicaid beneficiaries’ access to essential and lifesaving medications, especially for patients with chronic or rare conditions? Find out what @CaregiverAction's Marvell Adams thinks: youtube.com/watch?v=1VW_-G_C…

Congress must ensure that advancements in #alzheimers care benefit everyone, especially for communities with higher rates of Alzheimer's. The #asapact would help remove access barriers and bring innovative new screenings within reach. Thanks to @FSHCC president Julio Fuentes for sharing this message.

7.2M Americans live with #Alzheimers. The #ASAPAct lets Medicare cover blood-based screening to detect it years earlier. Grateful to @SenatorCollins, @CortezMasto, @MarkWarner, @SenCapito, @VernBuchanan @RepPaulTonko for championing this! fightchronicdisease.org/post… #Fight4Health #ENDALZ

Thank you @SenFinance for taking up the rising costs of health care and solutions that can better support the millions of American individuals and families navigating one and often multiple chronic conditions. #Fight4Health

We urge policymakers to reject foreign pricing models that will not meaningfully improve patient affordability or access. #Fight4Health fightchronicdisease.org/post…